JOHNSON JOHNSON MEDICAL ASIA PACIFIC
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Asia Pacific experts uncover gender-based disparity in diagnosis, treatment, and management of Atrial Fibrillation 2022-12-06 10:28
Asia Pacific experts uncover gender-based disparity in diagnosis, treatment, and management of Atrial Fibrillation 2022-11-17 10:00
Regional tuberculosis forum shines spotlight on innovation and collaboration driving progress toward ending tuberculosis in Asia Pacific 2021-12-14 10:00
First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischemic stroke in Asia Pacific 2021-04-01 11:15
Annual SEA Mental Health Forum finds partnerships, innovation, and access as key solutions to tackling positive correlation between mental illness and COVID-19 2020-10-27 16:23
Catheter Ablation 10x More Effective in Delaying Atrial Fibrillation Progression than Drug Therapy 2020-09-29 10:35
Ethicon #OrthopaedicMasters Webinar Series Featuring International Experts Sets Out to Improve Patient Outcomes 2020-07-28 10:30
Meta-Analysis from Biosense Webster, Inc. Reveals Positive Effects of Real-Time Ultrasound Imaging During Cardiac Ablation to Treat Arrhythmias 2020-07-20 11:25
Atrial Fibrillation Projected to Affect 72 Million People in Asia Pacific by 2050 According to New Report from Biosense Webster 2019-10-30 10:00
Johnson & Johnson Pte. Ltd. to Establish Big Data Center of Excellence In Singapore 2015-04-16 13:17
1